Christoph Esslinger

1.2k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Christoph Esslinger is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Christoph Esslinger has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Christoph Esslinger's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). Christoph Esslinger is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). Christoph Esslinger collaborates with scholars based in Switzerland, Germany and United States. Christoph Esslinger's co-authors include Heike L. Pahl, Lars E. French, Kimberly Burns, Jürg Tschopp, Jean-Luc Bodmer, Francesco Di Marco, Fabio Martinon, Pascal Schneider, H. Robson MacDonald and Isabelle Miconnet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Christoph Esslinger

13 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MyD88, an Adapter Protein Involved in Interleukin-1 Signaling

1998 532 citations Kimberly Burns, Fabio Martinon et al. Journal of Biological Chemistry profile →

Peers

Christoph Esslinger

IMMUN

MB

CR

GENET

ONCOL

Ashutosh Kumar United States

Sonia Feau United States

Kyoko Kurosawa United States

Kamal U. Saikh United States

Kyoko Shida Japan

Mark A. Chua United States

Isabelle Miconnet France

Nadine M. Turza Germany

Marcin Łyszkiewicz Germany

Thi Lien-Anh Nguyên Belgium

Ashutosh Kumar United States

Christoph Esslinger

640 ×0.9

IMMUN

816 ×2.6

MB

178 ×0.7

CR

100 ×0.5

GENET

145 ×0.8

ONCOL

Citations per year, relative to Christoph Esslinger Christoph Esslinger (= 1×) peers Ashutosh Kumar

Countries citing papers authored by Christoph Esslinger

Since Specialization

Citations

This map shows the geographic impact of Christoph Esslinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Esslinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Esslinger more than expected).

Fields of papers citing papers by Christoph Esslinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Esslinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Esslinger. The network helps show where Christoph Esslinger may publish in the future.

Co-authorship network of co-authors of Christoph Esslinger

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Esslinger. A scholar is included among the top collaborators of Christoph Esslinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Esslinger. Christoph Esslinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Huynh‐Do, Uyen, et al.. (2025). A highly potent human antibody neutralizing all serotypes of BK polyomavirus. PLoS Pathogens. 21(7). e1013122–e1013122. 1 indexed citations

2.

Hillenbrand, Matthias, Christoph Esslinger, Andreas Zingg, et al.. (2024). Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening. Viruses. 16(3). 339–339. 5 indexed citations

3.

Esslinger, Christoph, et al.. (2017). Why were 800 m of the Boßler Tunnel built twice? – TBM passing a shotcrete section. Geomechanics and Tunnelling. 10(2). 145–159. 2 indexed citations

4.

Gupta, Anurag, Natko Nuber, Christoph Esslinger, et al.. (2013). A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. PubMed. 13. 3–3. 17 indexed citations

5.

Esslinger, Christoph, Laurence Chapatte, Daniela Finke, et al.. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses. Journal of Clinical Investigation. 111(11). 1673–1681. 120 indexed citations

6.

Esslinger, Christoph, Laurence Chapatte, Daniela Finke, et al.. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses. Journal of Clinical Investigation. 111(11). 1673–1681. 114 indexed citations

7.

Esslinger, Christoph, Pedro Romero, & H. Robson MacDonald. (2002). Efficient Transduction of Dendritic Cells and Induction of a T-Cell Response by Third-Generation Lentivectors. Human Gene Therapy. 13(9). 1091–1100. 62 indexed citations

8.

Knecht, Hans, Christoph Berger, Cathy McQuain, et al.. (1999). Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Oncogene. 18(50). 7161–7167. 16 indexed citations

9.

Burns, Kimberly, Fabio Martinon, Christoph Esslinger, et al.. (1998). MyD88, an Adapter Protein Involved in Interleukin-1 Signaling. Journal of Biological Chemistry. 273(20). 12203–12209. 532 indexed citations breakdown →

10.

Esslinger, Christoph, C. Victor Jongeneel, & H. Robson MacDonald. (1998). Survival-independent function of NF-κB⧹Rel during late stages of thymocyte differentiation. Molecular Immunology. 35(13). 847–852. 10 indexed citations

11.

Esslinger, Christoph, et al.. (1997). Abnormal T lymphocyte development induced by targeted overexpression of IkappaB alpha. The Journal of Immunology. 158(11). 5075–5078. 63 indexed citations

12.

Hengel, Hartmut, Christoph Esslinger, J. Pool, Els Goulmy, & Ulrich H. Koszinowski. (1995). Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. Journal of General Virology. 76(12). 2987–2997. 68 indexed citations

13.

Esslinger, Christoph, Stéphane Picot, & P Ambroise-Thomas. (1994). Intra‐Erythrocytic Plasmodium falciparum Induces Up‐Regulation of Inter‐Cellular Adhesion Molecule‐1 on Human Endothelial Cells In Vitro. Scandinavian Journal of Immunology. 39(3). 229–232. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact